Objectives
==========

We performed a detailed analysis of the newly developing immune system in patients treated with autologous stem-cell transplantation (ASCT) for severe autoimmune diseases with special respect to the origin and the kinetics of repopulating B-cell and T-cell subsets in correlation to the clinical response.

Methods
=======

Peripheral blood lymphocytes were analyzed using multiparameter flow cytometry, including monitoring of the TCR-Vbeta repertoire on CD4^+^Th cells. Thymic activity was determined assessing absolute counts of peripheral blood CD31^+^thymic naive Th cells.

Patients and results
====================

Thirteen patients with a median follow-up of 54 months have so far been included in the trial: polychonditis (*n*= 1), systemic lupus erythematosus (SLE) (*n*= 6), systemic sclerosis (SSc) (*n*= 3), panniculitis (*n*= 1) and multiple sclerosis (*n*= 2). Clinical remission has been achieved in all patients with polychondritis (*n*= 1), SLE (*n*= 6) and multiple sclerosis (*n*= 2) whereas we observed progression of disease in all patients with SSc (*n*= 3) and panniculits (*n*= 1). One SLE patient relapsed after being free of any clinical and serological symptoms for 17 months.

T-lymphocyte compartments reconstituted functionally in all patients, indicated by the reappearance and persistence of CD45RA^+^CD31^+^thymic naive Th cells in high numbers with high levels of T-cell receptor excision circles and restored diversity of the Th-cell-receptor repertoire. In terms of Th-cell memory no autoreactive Th cells could be detected in responding patients. Reconstituted B cells were primarily of naïve phenotype (IgD^+^CD27^-^) in the first 12--18 months after ASCT. As a cellular marker for disease activity, frequencies of CD19^+^CD27^++^CD20^-^plasma blasts, elevated in SLE patients prior to ASCT, normalized after treatment in all patients. In case of the non-responding patients with SSc, autoantibody titers were not affected by treatment. However, no major differences in the pattern of lymphocyte reconstitution could be detected as compared with responding patients.

Conclusion
==========

The newly developing immune system after immunoablative therapy could be characterized as \'juvenile\' in all patients. However, in some patients the regeneration of a naive immune system alone seems not to be sufficient to regain self-tolerance. We conclude that both the resetting of central and peripheral tolerance and the efficient eradication of autoreactive lymphocytes seem to be a prerequisite for stable induction of remission.
